Long-Acting Therapies Trials Tracker for Malaria, Hepatitis C Virus, and Opioid Use and Overdose Prevention

As a partner in the LONGEVITY project, Treatment Action Group (TAG) released a trials tracker, an update of the 2025 Long-Acting Therapies Trials Tracker for Hepatitis C Virus, Opioid Use, and Overdose Prevention Therapy and Malaria, providing a compilation of ongoing clinical trials on long-acting therapies for HCV, malaria, and opioid use and overdose prevention therapy in the research and development pipeline.

The trials in the tracker are listed on the World Health Organization International Clinical Trials Registry Platform website, the Pan African Clinical Trials Registry, the European Union Clinical Trials Register, and the United States clinicaltrials.gov website.

The clinical trials were compiled between May 8 and June 4, 2026, and will be updated on an annual basis. Please send updates, corrections, or suggestions to Joelle Dountio Ofimboudem at jdountio@treatmentactiongroup.org.